Adenovirus type 4 a
Ended Awarded
- Contract number
- SPE2DP26F6533
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $171,763
Award facts
- Contract value 100% obligated
- $171,763.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense's Medical Supply Chain issued a $171,763.20 delivery order to Teva Pharmaceuticals USA, Inc. on June 16, 2026, for Adenovirus Type 4 vaccine, with an ultimate completion date of June 23, 2026.
The order is firm fixed price with no set-aside. Place of performance is Parsippany, New Jersey. The source does not identify the parent IDC vehicle by name or number, though Teva's federal profile indicates substantial prior delivery-order activity against Defense Logistics Agency Troop Support Medical's Adenovirus Type 4 vaccine contract.
Quick answers
Who was awarded contract SPE2DP26F6533?
SPE2DP26F6533 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on June 16, 2026.
How much is contract SPE2DP26F6533 worth?
The government has obligated $171,763 on SPE2DP26F6533.
Is contract SPE2DP26F6533 an order under another contract?
Yes. SPE2DP26F6533 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F6533 competed?
The extent of competition for SPE2DP26F6533 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award